A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Female; ≥18 years of age
• Presents to clinic with a confirmed diagnosis of a gynecologic cancer (e.g., ovarian, endometrial, cervical, or vulvar cancer) who have completed adjuvant chemotherapy with at least stable disease at time of screening.
• Screen positive for subjective cognitive impairment by answering affirmatively to at least one of three screener questions
• Fluent in spoken and written English
• Have access to the internet to complete assessments
Locations
United States
Illinois
Northwestern University
RECRUITING
Chicago
Contact Information
Primary
Anne Grace, PhD
anne@northwestern.edu
312-503-4165
Backup
Isabelle Kildee
isabelle.kildee@northwestern.edu
312-472-5726
Time Frame
Start Date: 2025-02-07
Estimated Completion Date: 2028-12
Participants
Target number of participants: 60
Treatments
Experimental: GYNCOG Intervention
Participants in the GYNCOG arm will be asked to participate in a home-based cognitive training program utilizing BrainHQ on study-provided tablets.
No_intervention: Control Group
Patients in the Control Group arm will receive usual care with no cognitive intervention.
Related Therapeutic Areas
Sponsors
Collaborators: Friends of Prentice
Leads: Northwestern University